KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,350,818 | -22.1% | 203,151 | -0.1% | 0.02% | -19.0% |
| Q2 2023 | $44,092,165 | +23.5% | 203,330 | +3.5% | 0.02% | +16.7% |
| Q1 2023 | $35,700,423 | -7.5% | 196,545 | +0.0% | 0.02% | -10.0% |
| Q4 2022 | $38,612,250 | -12.8% | 196,500 | -0.2% | 0.02% | -16.7% |
| Q3 2022 | $44,291,000 | +39.9% | 196,912 | -21.3% | 0.02% | +50.0% |
| Q2 2022 | $31,662,000 | +9.7% | 250,279 | +9.9% | 0.02% | +33.3% |
| Q1 2022 | $28,865,000 | +3.2% | 227,664 | +6.6% | 0.01% | +20.0% |
| Q4 2021 | $27,969,000 | +9.6% | 213,500 | +2.3% | 0.01% | 0.0% |
| Q3 2021 | $25,530,000 | +7.7% | 208,700 | +0.4% | 0.01% | +11.1% |
| Q2 2021 | $23,698,000 | -1.4% | 207,900 | +4.0% | 0.01% | -10.0% |
| Q1 2021 | $24,034,000 | – | 199,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |